INGREZZA® (valbenazine) capsules is an FDA-approved treatment for adults with the uncontrollable movements of tardive dyskinesia (TD).

Are your uncontrolled movements always in the spotlight?

Actor portrayals

Are your uncontrolled movements always in the spotlight?

If you have persistent, uncontrollable movements and are taking certain mental health meds, it’s time to ask your healthcare provider about a treatable condition called tardive dyskinesia (TD).

INGREZZA is different. It's the simple, once-daily treatment proven to reduce TD that's #1 prescribed.

Since TD is unlikely to get better on its own, it’s important to take control and talk to your healthcare provider about treatment.

Actor portrayals

Many people taking INGREZZA 80 mg in a clinical study started to see improvements in as little as 2 weeks,* and 7 out of 10 people had reduced movements at 6 weeks.

*INGREZZA was studied in a 6-week clinical trial. A total of 234 people participated in the study. Results were based on 79 people taking the recommended dose of 80 mg.

Patients had at least a 1-point reduction on an uncontrollable movement severity scale at 6 weeks vs before treatment. This post-clinical study evaluation included 70 patients taking INGREZZA 80 mg, measuring uncontrollable movements before starting treatment and at 6 weeks of treatment.

INGREZZA and your mental health

In a clinical study, psychiatric status remained stable overall in people taking INGREZZA for TD, including those who were also taking medicine for:

  • Depression
  • Bipolar disorder
  • Schizophrenia/schizoaffective disorder
  • Anxiety disorder
Learn more about treating TD with INGREZZA

Ready to take the next step?
Find a specialist.

You’ve worked hard to improve your mental health. Don’t let uncontrollable movements hold you back.

Take an important step forward by connecting with a psychiatry or neurology healthcare provider who has experience diagnosing and treating TD.

Find a specialist now

Receive emails to learn more about:

  • What you can expect while taking INGREZZA
  • What patient resources may be available
Actor portrayal

You are now leaving Ingrezza.com

Neurocrine Biosciences, Inc. is not responsible for the content of linked third-party websites. Please be aware that the privacy policies and terms of use on these sites are different from Neurocrine Biosciences, Inc. policies.